Company / Income Tax
Actinium Pharmaceuticals, Inc. Income Tax History
FY2011-FY2011 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-
FY2011
5-year range
-
FY2011-FY2011
Trend
-
vs FY2010
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2011 | $0 | - |
As of FY2011 · SEC 10-K · Updated Jun 24, 2026